BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 23486330)

  • 1. A rare case of ectopic adrenocorticotropic hormone syndrome caused by a metastatic neuroendocrine tumor of the pancreas detected by 68Ga-DOTANOC and 18F-FDG PET/CT.
    Treglia G; Salomone E; Petrone G; Giaccari A; Rindi G; Rufini V
    Clin Nucl Med; 2013 Jul; 38(7):e306-8. PubMed ID: 23486330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual tracer functional imaging of gastroenteropancreatic neuroendocrine tumors using 68Ga-DOTA-NOC PET-CT and 18F-FDG PET-CT: competitive or complimentary?
    Naswa N; Sharma P; Gupta SK; Karunanithi S; Reddy RM; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
    Clin Nucl Med; 2014 Jan; 39(1):e27-34. PubMed ID: 24217539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ectopic ACTH and CRH Co-secreting Tumor Localized by 68Ga-DOTA-TATE PET/CT.
    Papadakis GZ; Bagci U; Sadowski SM; Patronas NJ; Stratakis CA
    Clin Nucl Med; 2015 Jul; 40(7):576-8. PubMed ID: 26018709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoma as a second malignancy in a patient with neuroendocrine tumor: mimicking dedifferentiation on dual-tracer PET/CT with 68Ga-DOTANOC and 18F-FDG.
    Jain S; Sharma P; Dhull VS; Bal C; Kumar R
    Clin Nucl Med; 2014 Apr; 39(4):358-9. PubMed ID: 24217543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An unusual case of ectopic ACTH syndrome due to primary retroperitoneal carcinoid.
    Kasaliwal R; Malhotra G; Lila A; Bandgar T; Shah NS
    Clin Nucl Med; 2015 Apr; 40(4):364-7. PubMed ID: 25608172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors?
    Has Simsek D; Kuyumcu S; Turkmen C; Sanlı Y; Aykan F; Unal S; Adalet I
    J Nucl Med; 2014 Nov; 55(11):1811-7. PubMed ID: 25315243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative characterization of indeterminate large adrenal masses with dual tracer PET-CT using fluorine-18 fluorodeoxyglucose and gallium-68-DOTANOC: initial results.
    Naswa N; Sharma P; Soundararajan R; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
    Diagn Interv Radiol; 2013; 19(4):294-8. PubMed ID: 23439252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
    Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
    J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifocal extra-adrenal paraganglioma evaluated with different PET tracers: comparison between 18F-FDG, 18F-DOPA and 68Ga DOTANOC PET/CT.
    Treglia G; Cardillo G; Stefanelli A; Di Franco D; Enang GN; Giordano A; Rufini V
    Clin Nucl Med; 2013 Dec; 38(12):e458-62. PubMed ID: 23486329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 68Ga-DOTANOC and 18F-FDG PET-CT Scans in the Evaluation of Primary Tumors and Lymph Node Metastasis in Patients With Rectal Neuroendocrine Tumors.
    Zhou Z; Wang Z; Zhang B; Wu Y; Li G; Wang Z
    Front Endocrinol (Lausanne); 2021; 12():727327. PubMed ID: 34539577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography.
    Farchione A; Rufini V; Brizi MG; Iacovazzo D; Larghi A; Massara RM; Petrone G; Poscia A; Treglia G; De Marinis L; Giordano A; Rindi G; Bonomo L
    Pancreas; 2016 Mar; 45(3):345-54. PubMed ID: 26418904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 68Ga DOTANOC PET/CT in primary neuroendocrine tumor of the breast.
    Mukherjee A; Karunanithi S; Singla S; Bal C; Kumar R
    Clin Nucl Med; 2014 Apr; 39(4):396-8. PubMed ID: 24566407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined 18F-FDG PET/CT and 68Ga DOTATATE PET/CT "Superscan" in Metastatic Pancreatic Neuroendocrine Tumor.
    Chan M; Schembri GP
    Clin Nucl Med; 2017 Feb; 42(2):108-109. PubMed ID: 27997429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18Flurodeoxyglucose positron emission tomography in the localization of ectopic ACTH-secreting neuroendocrine tumours.
    Kumar J; Spring M; Carroll PV; Barrington SF; Powrie JK
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):371-4. PubMed ID: 16584507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When should F-18 FDG PET/CT be used instead of 68Ga-DOTA-peptides to investigate metastatic neuroendocrine tumors?
    Fuccio C; Musto A; Cambioli S; Castellucci P; Pantaleo MA; Nanni C; Montini GC; Campana D; Tomassetti P; Bellan E; Massaro A; Grassetto G; Rubello D; Fanti S
    Clin Nucl Med; 2011 Dec; 36(12):1109-11. PubMed ID: 22064082
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the prognostic values of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in patients with well-differentiated neuroendocrine tumor.
    Sharma P; Naswa N; Kc SS; Alvarado LA; Dwivedi AK; Yadav Y; Kumar R; Ammini AC; Bal C
    Eur J Nucl Med Mol Imaging; 2014 Dec; 41(12):2194-202. PubMed ID: 25030618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-tracer PET/CT imaging to determine tumor heterogeneity in a patient with metastatic ACTH-secreting neuroendocrine neoplasm: A case report and literature review.
    Ryzhkova D; Mitrofanova L; Tsoy U; Grineva E; Schlyakhto E
    Front Endocrinol (Lausanne); 2022; 13():958442. PubMed ID: 36133304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
    Yao J; Gan G; Farlow D; Laurence JM; Hollands M; Richardson A; Pleass HC; Lam VW
    ANZ J Surg; 2012 Mar; 82(3):140-4. PubMed ID: 22510123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of diagnostic efficacy of
    Zhang B; He Q; Long Y; Zhang Y; Wang X; Chen Z; Liu J; Zhang X
    Front Endocrinol (Lausanne); 2022; 13():962800. PubMed ID: 36213295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrapancreatic accessory spleen detected by 68Ga DOTANOC PET/CT and 99mTc-colloid SPECT/CT scintigraphy.
    Collarino A; del Ciello A; Perotti G; Rufini V
    Clin Nucl Med; 2015 May; 40(5):415-8. PubMed ID: 25275421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.